Teva Pharmaceutical Industries Limited
TEVJF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$45.92B
Close$
$48.83
25.3% upside
Current Fair Value
25.3% upsideUndervalued by 25.3% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $45.92 Billion |
|---|---|
| Enterprise Value | $59.14 Billion |
| Earnings per Share | $1.23 |
| Beta | 0.93 |
| Outstanding Shares | 1,165,000,000 |
Return
| Return on Equity | 9.10% |
|---|---|
| Return on Assets | 1.77% |
| Return on Invested Capital | 7.58% |
Valuation & Multiples
| P/E Ratio | 62.25 |
|---|---|
| PEG | -20.46 |
| Price to Sales | 2.78 |
| Price to Book Ratio | 6.5 |
| Enterprise Value to Revenue | 3.42 |
| Enterprise Value to EBIT | 32.23 |
| Enterprise Value to Net Income | 83 |
| Total Debt to Enterprise | 0.29 |
| Debt to Equity | 2.18 |
Revenue Sources
No data
Last Earnings Call
Report Date
July 29, 2026
EPS Estimate
$0.05
Consensus analyst estimateRevenue Estimate
$4.08 B
Consensus analyst estimateNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$0.69
Consensus analyst estimateRevenue Estimate
$4.22 B
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Teva- Pharmaceutical Industries Ltd.
33,346 employees
CEO: Kaare Schultz
Teva Pharmaceutical Industries Limited operates as a prominent global pharmaceutical firm, involved in the research, development, manufacturing, marketing, and distribution of generic, specialized, and biopharmaceutical products througho...